“Adalimumab and Etanercept in the Treatment of Rheumatoid Arthritis and Spondyloarthropathies: Budget Impact Model of Dose Reduction ”, J. Pharm. Nutr. Sci., vol. 4, no. 3, pp. 170–176, Jun. 2014, doi: 10.6000/1927-5951.2014.04.03.1.